Free Head and Neck Cancer Screenings
Friday, April 26
8 a.m.-4 p.m.
Ohio State's Eye and Ear Institute
915 Olentangy River Rd.
4th Floor Clinic
Columbus, 43212
If you are suffering from any of these symptoms, call The James Line to schedule an appointment:
• Persistent sore(s) of the mouth
• Hoarseness lasting longer than three weeks
• Sore throat that persists for more than six weeks
• Swelling in the neck for more than six weeks
Even if you have no symptoms, you may want to schedule an appointment, particularly if you smoke or use alcohol.
Call The James Line at 614-293-5066 or 800-293-5066 to make your appointment.
*Appointments will be scheduled on a first-come, first-served basis. Complimentary parking provided in the attached surface lots.
For a downloadable flyer, click here.
Most head and neck cancers begin in the mucosal surfaces in the mouth, nose and throat. Included are cancers of the oral cavity, salivary glands, paranasal sinuses and nasal cavity, pharynx, larynx, and the lymph nodes in the upper part of the neck. Head and neck cancers are highly treatable and the cure rate is good if they are detected early.
The Head and Neck Oncology Program at Ohio State's Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute is at the forefront of national efforts to improve the outcome of patients treated for head and neck malignancies. The program comprises 14 members from nine departments in three colleges.
The focus of the Head and Neck Oncology Program is on the development and support of research and educational activities to improve the detection, prevention, rehabilitation and quality-of-life issues relating to head and neck cancers. In addition, one of the program's goals is to further develop translational, interdisciplinary research and educational programs. The program is one of the largest accruing institutions to local and national head and neck clinical trials.
Some of the Head and Neck Oncology Program's past research accomplishments include:
- Conducted some of the first studies in the United States demonstrating that certain head and neck cancers are responsive to chemotherapy.
- Participated in the leadership group which conducted a national trial demonstrating a dramatic improvement in cure rates using chemotherapy and radiotherapy for nasopharyngeal cancer, the second most common malignancy in the world. This treatment approach is now the standard of care for the disease.
- Developed a new operation and treatment approach for tumors invading the anterior skull base which increases local tumor control and decreases the treatment morbidity.
- Developed a treatment approach for advanced stage resectable mouth and throat cancers which has dramatically improved the local disease control rates and offers hope for improved cure rates.
- Developed numerous new reconstructive surgical approaches for the throat, voice box, and windpipe.
- Used microarray technology to generate a tumor-specific gene expression profile for squamous cell carcinoma of the head and neck, identifying gene-specific causative and prognostic biomarkers for the disease.
Learn more about Supporting Head and Neck Research at The James through the Joan Bisesi Fund.
This section of the Web site will give you access to:
If you have questions about head and neck cancer, please call The James Line – a free cancer information resource and physician referral service – at 614-293-5066 or 1-800-293-5066 (outside Franklin County) or e-mail now. The James Line oncology nurses can be reached Monday-Friday 8:00 a.m.-5:00 p.m. (except weekends and holidays).View The James' head and neck cancer fact sheet.
The Head and Neck Oncology Program is located on the first floor of The James Cancer Hospital and Solove Research Institute, located at 300 W. 10th Ave., Columbus, Ohio 43210. For more information about our services, please contact us at (614) 293-8074.
To learn more about your physician and treatment options through the Department of Otolaryngology-Head & Neck Surgery, click here.